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Fast and efficient three-step 
target-specific curing of a virulence plasmid 
in Salmonella enterica
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Abstract 
Virulence plasmids borne by serovars of Salmonella enterica carry genes involved in its pathogenicity, as well as other 
functions. Characterization of phenotypes associated with virulence plasmids requires a system for efficiently curing 
strains of their virulence plasmids. Here, we developed a 3-step protocol for targeted curing of virulence plasmids. The 
protocol involves insertion of an I-SecI restriction site linked to an antibiotic resistance gene into the target plasmid 
using λ-Red mutagenesis, followed by the transformation with a temperature-sensitive auxiliary plasmid which carries 
I-SecI nuclease expressed from a tetracycline-inducible promoter. Finally, the auxiliary plasmid is removed by incuba-
tion at 42 °C and the plasmid-less strains are verified on antibiotic-containing media. This method is fast and very 
efficient: over 90 % of recovered colonies lacked their virulence plasmid.
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Introduction
In many pathogens, including Salmonella enterica, viru-
lence determinants are often carried on plasmids (rev. 
Etcheverria and Padola 2013; Fabrega and Vila 2013). 
Virulence plasmids are found in Salmonella enterica 
serovars Abortusovis, Choleraesuis, Dublin, Enteritidis, 
Gallinarum/Pullorum, Paratyphi C, Sendai, and Typh-
imurium (Akiba et al. 1999; Barrow and Lovell 1988; Bar-
row et  al. 1987; Danbara et  al. 1992; Gulig and Curtiss 
1987; Libby et  al. 1997; Liu et  al. 2009; Nakamura et  al. 
1985; Ou et al. 1990), all of which are of medical or vet-
erinary concern. These plasmids function as virulence 
determinants, contributing to pathogenesis of S. enterica, 
especially during the systemic phase of the disease (Libby 
et al. 1997; Uzzau et al. 2000). Virulence plasmids vary in 
size, ranging from 50 kb (sv. Choleraesuis) to 285 kb (sv. 
Sendai) (Feng et  al. 2012). Despite overall differences in 
composition, some genetic components are conserved, 
most notably the virulence determinant spv operon which 
is expressed during infection and codes for SpvB, a toxin 
that ADP-ribosylates actin of the macrophage cell desta-
bilizing its cytoskeleton (Heithoff et  al. 1997; Lesnick 
et al. 2001; Tezcan-Merdol et al. 2001) and SpvC, a phos-
phothreonine lyase that helps subvert natural inflamma-
tion response to Salmonella enterica (Haneda et al. 2012; 
Mazurkiewicz et al. 2008). Intra-serovar diversity in plas-
mid composition has also been reported, although, on 
a more limited scale. For example, insertions led to the 
acquisition of antibiotic resistance genes in the virulence 
plasmid of the serovar Typhimurium, thus making it not 
only a virulence determinant, but also the source a multi-
drug resistance phenotype (Herrero-Fresno et al. 2015).
Defining functions of virulence plasmids requires a 
process known as “plasmid curing”. Different methods 
were developed to cure bacteria of their virulence plas-
mids, they involve heat or chemical treatments to exclude 
the plasmid from the cell. Substances with DNA interca-
lating properties, gyrase inhibiting effects and selections 
against phenotypes associated with the plasmid were 
successfully employed in different bacterial species and 
plasmids [rev. (Trevors 1986)]. However, these meth-
ods have some important caveats: treatment with harsh 
chemicals that affect properties of DNA or functions 
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of DNA replicating machine tend to select for mutants 
(although this effect has not been exhaustively explored). 
Counter-selection, using sensitivity to sucrose or fusaric 
acid (encoded by sacB or tetRA, respectively) can be fas-
tidious and time-consuming, with low efficiency.
An alternative to methods based on chemical or tem-
perature stresses is the curing by incompatibility. To this 
end, the host bacterium is transformed with a second 
plasmid from the same incompatibility group, this plas-
mid interferes with the replication of the native plasmid 
by competing for the replication and partitioning sys-
tems or interfering with the ability of the plasmid to cor-
rect fluctuations in its copy number (Novick 1987; Tinge 
and Curtiss 1990). To increase the potential of interfering 
with the resident plasmid, the secondary plasmid is usu-
ally smaller, high copy and carries an antibiotic marker 
to help the process with selective pressure. Despite the 
advantages, this system also requires the same counter-
selective methods to remove the secondary plasmid from 
the host.
In this paper we describe a new system to cure the vir-
ulence plasmid of Salmonella enterica that is based on 
the λ-Red recombination and I-SecI meganuclease. This 
method differs from all other approaches because it is not 
based on exposure to stress or the use of incompatibility 
plasmids. It does not require fastidious counter-selection 
and works with high efficiency: over 90 % of the recov-
ered colonies were cured of the virulence plasmid.
Materials and methods
Bacterial strains and culture conditions
Bacterial strains and plasmids used in this study are listed 
in Table  1. S. enterica and Escherichia coli strains were 
propagated in LB (Luria–Bertani) broth (Fisher Scien-
tific) at 37  °C unless otherwise specified in this text. As 
appropriate, media were supplemented with 100  µg/ml 
ampicillin or 20 µg/ml chloramphenicol.
The effect of different concentrations of anhydrotet-
racycline (AHT) on bacterial growth was analyzed by 
growth curves of S. enterica sv. Typhimurium MHM21 
pMHM199. Overnight cultures were adjusted to 
OD600 = 0.01 in LB medium with 100 µg/ml ampicillin, 
and 200 µl of the culture were transferred to a well of a 
96-wells plate with a range of AHT concentrations (0, 
125, 500 and 1,000  ng/ml), with each condition assayed 
in triplicates. The plate was incubated in a plate reader 
(Victor3, Perkinelmer) at 30  °C and the absorbance at 
590 nm was measured hourly.
Cloning and strains construction
Plasmid pMHM199 was constructed by amplifying I-SecI 
gene under the tetracycline inducible promoter PtetA, the 
regulator tetR, and the ampicillin resistance gene as well 
as the oriR101 origin of replication and temperature-
sensitive repA101ts with primers CGAAATCCACT 
GAAAGCACA and AAGCTGCTTTTGAGCACCAC 
using pWRG99 (Blank et al. 2011) as a template and Q5® 
High-Fidelity DNA Polymerase (New England Labs). 
The resulting amplicon was treated with T4 DNA Ligase 
(New England Biolabs) under the conditions that favor 
intra-molecular ligation. The resulting plasmid was con-
firmed by the restriction digest. pMHM199 carries the 
endonuclease I-SecI under the promoter responsive to 
anhydrotetracycline PtetA.
The cassette containing the I-SecI site and chloram-
phenicol resistance gene was amplified from the template 
pWRG100 with primers (MHM91 ATGAATATGAATCA 
GACCACCAGTCCGGCACTTTCACAGGTCGAAAC 
CGCCGCCTTACGCCCCGCCCTGC and MHM92 
CTAAACTGCCGGCTGGC ACGC AGAGTACCCG 
CAATCAACTGTTCCACCTGCTAGACTATATTAC 
CCTGTT, where boldface letters indicate regions of 
homology with pWRG100 and italicized letters indicate 
homology with the spvA gene) using OneTaq®  DNA 
polymerase. The resulting PCR fragment was inserted 
in the place of the spvA gene by λ-Red recombination 
(Datsenko and Wanner 2000). Briefly, electrocompe-
tent cells were prepared using Salmonella enterica sv. 
Table 1 Strains used in the study
Strains Characteristic References
S. enterica sv. Typhimurium ATCC 14028 Wild type ATCC
S. enterica sv. Typhimurium MHM21 spvA::cat, I-SecI recognition site This study
S. enterica sv. Typhimurium MHM113 Lacks virulence plasmid p14028 This study
Plasmids
 pWRG100 cat, I-SecI recognition site (Blank et al. 2011)
 pWRG99 λ-Red genes under control of arabinose inducible promoter (PBAD), I-SecI endonuclease 
under control of tetracycline inducible promoter (PtetA), temperature sensitive, Amp
R
(Blank et al. 2011)
 pMHM199 I-SecI endonuclease under control of tetracycline inducible promoter (PtetA), temperature 
sensitive, AmpR
This study
Page 3 of 6de Moraes and Teplitski  AMB Expr  (2015) 5:52 
Typhimurium 14028 harboring pKD46 grown in LB 
broth at 30  °C supplemented with 100  µg/ml ampicil-
lin and 10  mM l-arabinose until OD600  =  0.6–0.8, for 
approximately 3–4 h.
The spvA PCR cassettes (10–50 ng) were electroporated 
into 50 µl aliquots of electrocompetents cells. Electropo-
rations were carried out using MicroPulser (BioRad) 
using manufacturer’s instructions. Cells were recov-
ered in SOB (Super Optimal Broth) containing 2 % w/v 
tryptone, 0.5 % w/v yeast extract, 10 mM NaCl, 10 mM 
MgCl2, 2.5  mM KCl (Sambrook and Russell 2001) and 
plated onto LB agar with 20 µg/ml chloramphenicol. The 
insertion was transduced into S. enterica sv. Typhimu-
rium 14028 by phage P22. All insertions were confirmed 
by PCR (MHM29 CAGAATGGTCTGCTGCTCAC and 
MHM30 GGATTTCATTCTGTTTATTTTCAGG).
Efficiency of the plasmid curing system
Approximately 100  ng of purified pMHM199 were 
added to 50  µl of electrocompetent cells prepared from 
MHM21 strain. The cells were electroporated in 0.2 cm 
gap cuvettes with a MicroPulser (BioRad). Cells were 
resuspended in 1 ml of SOB medium and recovered for 
1  h at 30  °C. The cells were divided in 350  µl aliquots 
and plated onto LB agar with 100  µg/ml ampicillin and 
supplemented with 0, 125 or 500 ng/ml AHT. The plates 
were incubated at 30 °C overnight. After the incubation, 
50 colonies from each treatment were patched onto a 
new LB agar 100  µg/ml ampicillin plate and incubated 
at 30  °C overnight to purify the colonies and ensure 
that only bacteria carrying pMHM199 were present. 
The colonies were transferred to a new LB agar 20  µg/
ml chloramphenicol plate and incubated at 37  °C over-
night. The colonies that grew showing chloramphenicol 
resistance were defined as carrying pLST and the colo-
nies that were chloramphenicol sensitive were defined 
as cured from pLST. To confirm the curing of pLST, the 
DNA from three chloramphenicol sensitive colonies and 
MHM21 as control were extracted using GenElute Bac-
terial DNA kit (Sigma-Aldrich) for a PCR targeting the 
plasmid genes repA (MHM1 GGCTATAGAGTGCG 
GTCTGG and MHM2 TCCGTGCAGTTTACGTTCAG, 
spvA (MHM29 and MHM30) and the chromosomal 
gene phoN (MHM7 TCATTTGCTGTGGCCAGTT and 
MHM8 TTATTGCCTGATCCGGAGTG) as a control.
Results
Plasmid curing
The procedure for the technique is shown in Fig.  1. 
The first step (Fig.  1a) requires PCR amplification 
of the I-SecI site and a chloramphenicol resistance 
gene (cat) using pWRG100 as a template. The PCR 
primers included regions of homology to pWRG100 
CGCCTTACGCCCCGCCCTGC and CTAGACTATAT 
TACCCTGTT on the 3′ ends (Blank et  al. 2011). The 
PCR product replaced spvA gene of pSLT using λ-Red 
recombination (Datsenko and Wanner 2000). The result-
ing strain (MHM21 pSLT-cat) was confirmed to be resist-
ant to chloramphenicol and the presence of the I-SecI site 
was confirmed by PCR (Fig. 1b).
The next step (Fig. 1c) consisted of the electroporation 
of MHM21 pSLT-cat with the helper plasmid pMHM199, 
which carries the I-SecI endonuclease gene under the 
tetracycline-activated promoter PtetA and tetR. The trans-
formation reaction was directly plated onto LB agar con-
taining ampicillin 100 μg/ml to maintain pMHM199 and 
AHT that induces the expression of I-SecI (via TetR). 
Then, the I-SecI endonuclease targets the I-SecI site on 
the 5′ end of the cat gene, which linearizes the virulence 
plasmid, leading to its loss in the subsequent generations.
The pMHM199 is a low copy, temperature-sensitive 
plasmid with replication origin based on pSC101, which 
allows easy curing by growing the cells in 42  °C for 6 h. 
The last step consists in the selection and confirmation 
of colonies cured of pSLT, by first selecting colonies that 
were chloramphenicol sensitive followed by PCR target-
ing the plasmid genes spvA and repA. The use of two tar-
gets at distant position on the plasmid helps to avoid the 
selection of mutants with segment deletions and integra-
tion to the chromosome. The resultant colonies were also 
confirmed to be ampicillin-sensitive, indicating loss of 
pMHM199.
Effect of AHT on cell growth
Anhydrotetracycline (AHT) is a tetracycline derivative 
that has a higher affinity for TetR, allowing the chemi-
cal to be used as an inducer in vivo. However, AHT also 
exhibits bacteriostatic effects. To determine at which 
concentrations AHT is most effective as an inducer and 
less toxic to the cells, a growth curve with the strain 
MHM21 pMHM199 was constructed with a gradient of 
AHT concentrations (0, 125, 500, 1,000 ng/ml), as shown 
in Fig. 2. MHM21 pMHM199 was able to grow under all 
conditions, but growth inhibition was observed under 
the the higher concentrations (500, 1,000  ng/ml) while 
growth in media containing less than 125 ng/ml remained 
close to the negative control. Because of the detrimental 
effects of concentration 1,000 ng/ml, it was exclude from 
further experiments to test the system efficiency.
Plasmid curing efficiency
After the strain MHM21 pSLT-cat was transformed with 
pMHM199, the cells were plated onto LB agar contain-
ing a range of AHT concentrations (0, 125, 500  ng/ml) 
to determine the efficiency and best condition for the 
plasmid curing method. To quantify the loss of virulence 
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plasmid, colonies were tested for chloramphenicol resist-
ance, and the loss of resistance was interpreted as loss of 
the plasmid. To confirm that the chloramphenicol-sus-
ceptible colonies did not harbor virulence plasmid, a PCR 
targeting plasmid genes spvA and repA and chromosomal 
gene phoN as a positive control was carried out. As 
expected all colonies were chloramphenicol resistant 
with the absence of AHT, and a surprisingly high number 
of colonies were sensitive to chloramphenicol after grow-
ing under AHT, 90 % for 125 ng/ml and 93 % for 500 ng/
Fig. 1 Steps involved in plasmid curing. a Plasmid pMHM199 contains I-SecI restriction endonuclease gene under the tetracycline inducible pro-
moter PtetA, the regulator tetR, and the ampicillin resistance gene as well as the oriR101 origin of replication and temperature-sensitive repA101ts. b 
Deletion cassette is built by PCR using primers ATGAATATGAATCAGACCACCAGTCCGGCACTTTCACAGGTCGAAACCGCCGCCTTACGCCCCGCCCTGC 
and CTAAACTGCCGGCTGGCACGCAGAGTACCCGCAATCAACTGTTCCACCTGCTAGACTATATTACCCTGTT and plasmid pWRG100 as a template [in 
bold, regions of homology with pWRG100 (Blank et al. 2011)]. The cassette contains the I-SecI site adjacent to the chloramphenicol resistance gene 
cat, flanked by the homology regions to spvA gene (H1 and H2). c λ Red recombination step. The homology regions on the insertion cassette 
recombine with the spvA plasmid gene by λ Red recombination, excluding the spvA and substituting it with the I-SecI site linked to the cat gene 
generating the strain MHM21. d In vivo digestion. The plasmid pMHM199 is electroporated into MHM21, which is then plated onto LB agar contain-
ing ampicillin to select the positive transformants, and anhydrotetracycline.
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ml. The loss of resistance was very similar for each treat-
ment, indicating that even under the lower tested AHT 
concentration the system was successful in curing the 
virulence plasmid. PCR amplification of spvA and repA 
failed in all chloramphenicol-susceptible colonies, indi-
cating that all chloramphenicol-sensitive isolates lost 
pSLT-cat (Fig. 3).
Discussion
Plasmids carry functions important for interactions of 
pathogenic and symbiotic bacteria with their hosts. In S. 
enterica, virulence plasmids encode functions involved 
in virulence (such as spv), contributing to pathogenesis 
of S. enterica, especially during the systemic phase of the 
disease (Libby et al. 1997; Uzzau et al. 2000). Elucidation 
of the phenotypes associated with virulence plasmids 
required their efficient curing from the bacterial cells.
Various methods have been used to generate plasmid-
less strains of S. enterica, however, most of them either 
have low efficiency or require that bacteria are cultured 
successively under the stressful conditions that likely 
result in the accumulation of second-site mutations. 
The method for curing virulence plasmids reported here 
is over 90  % efficient, which is significantly higher than 
10−6–10−7 per generation reported for the same plasmid 
using novobiocin (Gulig and Curtiss 1987) or using the 
incompatibility plasmid and destabilization of the par 
locus (Tinge and Curtiss 1990). The latter method was 
82 % efficient, however, 10 generations were required to 
achieve this level of efficiency (Tinge and Curtiss 1990).
The method described here could also be particularly 
useful in curing individual plasmids from strains that 
carry multiple plasmids. For example, multi-drug resist-
ant strains of S. enterica currently circulating in Europe 
(Garcia et  al. 2014) contain multiple plasmids, and the 
method described here could be used to efficiently 
remove individual plasmids. This method could also 
be used for the generation of vaccine strains, similar to 
the study of Matsui et al. (2015) who demonstrated that 
plasmid-cured S. enterica strains used as live vaccines 
have been tested as live vaccine strains providing nearly 
complete protection against virulent S. enterica in mice 
(Matsui et al. 2015).
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Fig. 2 Growth of MHM21 in LB medium supplemented with differ-
ent amounts of anydrotetracycline. Overnight cultures of MHM21 
(spvA::[I-SecI site, cat]) were adjusted to OD600 = 0.01 in LB medium 
with 100 µg/ml ampicillin. Two hundred microliters of the culture 
were transferred to wells of a 96-well plate with different concen-
trations of AHT (0, 125, 500 and 1,000 ng/ml) with each condition 
assayed in triplicates. The plate was incubated in a plate reader 
(Victor3, Perkin Elmer) at 30 °C and the absorbance at 590 nm was 
measured hourly.
Fig. 3 Confirmation of the loss of pSLT. Agarose gel (0.9 %) with PCR 
products to confirm curing of virulence plasmid. Lanes 1, 2 and 3 are 
reactions performed with strain MHM21 before plasmid curing; the 
strain cured of pSLT was used as a template in lanes 4, 5 and 6. Lanes 
1 and 4 contain PCR products targeting chromosomal gene phoN 
(amplified using TCATTTGCTGTGGCCAGTT and TTATTGCCTGATC 
CGGAGTG; lanes 2 and 5 contain PCR product stargeting spvA::[I-SecI 
site, cat] with CAGAATGGTCTGCTGCTCAC and GGATTTCATTCTGTT 
TATTTTCAGG; and lanes 3 and 6 contain PCR products targeting 
plasmid gene repA (with primers GGCTATAGAGTGCGGTCTGG and 
TCCGTGCAGTTTACGTTCAG).
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